Fierce Pharma

China’s National Healthcare Security Administration unveiled its first batch of [...]

After five years of follow-up on its hemophilia B gene [...]

Mark Cuban, the co-founder of online pharmacy Cost Plus Drugs, [...]

Pfizer has unveiled phase 3 results that could help the [...]

After a record-setting October that easily dwarfed all preceding months [...]

With FDA approval to treat marginal zone lymphoma, Bristol Myers [...]

On “The Top Line,” EY’s Arda Ural talks with Fierce [...]

Halozyme is seeing some progress in its global effort to [...]

The FDA is investigating a safety signal from Takeda’s rare [...]

A trio of drugmakers are treading the boards to raise [...]